← Leaderboards
David A. Ford
Saint Louis University
$8,569,404
Attributed
$11,679,953
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $867.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,018,953 · 17
By mechanism
R01$9,453,676 · 6
R21$1,642,923 · 4
S10$922,354 · 7
Top collaborators
- Jane Mchowat10 shared
- Ronald J Korthuis5 shared
- James L Edwards3 shared
- Rakesh Pravinchandra Patel3 shared
- Nuala Jennings Meyer1 shared
Most similar at Saint Louis University
Same institution · by research overlap
- James L Edwards$1,204,218
Others in their field
Top investigators on “Plasmalogens”
- Richard W Gross · Washington University$6,560,926
- Sadis Matalon · University Of Alabama At Birmingham$5,709,643
- John W Turk · Washington University$4,830,117
- Rakesh Pravinchandra Patel · Medical College Of Wisconsin$4,622,710
- Rima F Kaddurah-Daouk · Duke University$4,071,230
- Mitchel Allan Kling · Duke University$3,150,208
Research focus
PlasmalogensLipidsPlasmaAldehydesAcidsMediatingProductionFunctional DisorderNeutrophilMorbidity - Disease RateProteinsResponseMediator Of Activation ProteinVinyl EtherIn VivoOxidationEndothelial CellsPeroxidasesHypochlorous AcidBlood VesselsOrganMortalityRattusPathway Interactions
Grant awards (44)
Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity$303,000
R01 · FY2025 · ES · contact PI
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury$450,008
R01 · FY2024 · ES · contact PI
Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity$303,000
R01 · FY2024 · ES · contact PI
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury$450,008
R01 · FY2023 · ES · contact PI
Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity$303,000
R01 · FY2023 · ES · contact PI
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury$462,883
R01 · FY2022 · ES · contact PI
Chlorinated lipids in sepsis$321,193
R01 · FY2021 · GM · contact PI
Chlorinated lipid modification of proteins: Biomarkers of chlorine gas exposure$189,375
R21 · FY2021 · ES · contact PI
Chlorinated lipids in sepsis$59,387
R01 · FY2021 · GM · contact PI
Chlorinated lipids in sepsis$321,934
R01 · FY2020 · GM · contact PI
Chlorinated lipid modification of proteins: Biomarkers of chlorine gas exposure$227,250
R21 · FY2020 · ES · contact PI
Chlorinated lipids in sepsis$33,057
R01 · FY2020 · GM · contact PI
Chlorinated lipids in sepsis$335,527
R01 · FY2019 · GM · contact PI
Liquid Chromatography/ESI-MS Triple Quadrupole System$244,354
S10 · FY2019 · OD · contact PI
Chlorinated lipids in sepsis$422,547
R01 · FY2018 · GM · contact PI
Neutrophil-dependent mediators of sepsis$295,275
R01 · FY2018 · GM · contact PI
Chlorinated lipids in sepsis$150,000
R01 · FY2018 · GM · contact PI
Chlorinated lipids in sepsis$432,237
R01 · FY2017 · GM · contact PI
Chlorinated lipids in sepsis$459,926
R01 · FY2016 · GM · contact PI
Chlorinated lipids in sepsis$472,410
R01 · FY2015 · GM · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$367,500
R01 · FY2014 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$357,000
R01 · FY2013 · HL · contact PI
Chlorinated Lipids in Myocardial Ischemia/Reperfusion$178,500
R21 · FY2013 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$375,000
R01 · FY2012 · HL · contact PI
Chlorinated Lipids in Myocardial Ischemia/Reperfusion$225,000
R21 · FY2012 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$375,000
R01 · FY2011 · HL · contact PI
Serum chlorinated lipids as predictors of cardiovascular risk in lupus$189,073
R21 · FY2011 · HL · contact PI
Serum chlorinated lipids as predictors of cardiovascular risk in lupus$229,475
R21 · FY2010 · HL · contact PI
Novel MPO-derived plasma lipids as predictors of major adverse coronary events$183,750
R21 · FY2009 · HL · contact PI
Novel MPO-derived plasma lipids as predictors of major adverse coronary events$220,500
R21 · FY2008 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$313,611
R01 · FY2007 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$322,978
R01 · FY2006 · HL · contact PI
Plasmalogen-derived bioactive lipids in atherosclerosis$330,750
R01 · FY2005 · HL
TSQ Quantum ESI-MS Surveyor Bundle$339,000
S10 · FY2004 · RR
Plasmalogen-derived bioactive lipids in atherosclerosis$330,750
R01 · FY2004 · HL
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: C.NEOFORMS, FUNGAL PATHOLOGY$67,800
S10 · FY2004 · RR
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: DRUG ABUSE$67,800
S10 · FY2004 · RR
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: GENOMICS$67,800
S10 · FY2004 · RR
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: DIABETES$67,800
S10 · FY2004 · RR
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: RENAL, HEART, RETINAL, &LUNG DISEASES$67,800
S10 · FY2004 · RR
PLASMALOGEN CATABOLISM DURING MYOCARDIAL ISCHEMIA$297,296
R01 · FY2003 · HL
PLASMALOGEN CATABOLISM DURING MYOCARDIAL ISCHEMIA$288,636
R01 · FY2002 · HL
PLASMALOGEN CATABOLISM DURING MYOCARDIAL ISCHEMIA$280,229
R01 · FY2001 · HL
PLASMALOGEN CATABOLISM DURING MYOCARDIAL ISCHEMIA$239,534
R01 · FY2000 · HL